Researchers conducted a study at Asan Medical Center to assess the feasibility, effectiveness, and safety of EUS-guided radiofrequency ablation (EUS-RFA) for treating left adrenal tumors. The results were promising, with a 100% technical success rate in performing EUS-RFA. Most patients (73%) achieved a complete response after a median of 2 EUS-RFA sessions. Importantly, no moderate […]

In patients with nonmetastatic medullary thyroid cancer, researchers examined the use of hemithyroidectomy, a less extensive surgery, instead of total thyroidectomy. They identified two types of tumors, desmoplasia-negative and desmoplasia-positive, based on markers in the tumor tissue. The results showed that patients with desmoplasia-negative tumors who had hemithyroidectomy achieved a biochemical cure without compromising their […]

In the evaluation of disease progression within high-risk thyroid nodules during active surveillance, researchers compared the effectiveness of tracking tumor diameter versus volume. Among 468 patients with a total of 569 high-risk thyroid nodules, only 2.5% showed a significant diameter increase of ≥3 mm, while volume fluctuations of 50% and 100% were noted in 32.5% […]

The transoral endoscopic thyroidectomy vestibular approach (TOETVA) offers a cosmetic edge over traditional thyroid surgery. Researchers assessed TOETVA’s learning curve and its effectiveness in treating carcinoma showing thymus-like differentiation (CASTLE) tumors. The study found longer operation times in TOETVA, but it excelled in skin numbness and cosmetic outcomes. The learning curve analysis revealed that a […]

A study explored the outcomes of treating low-risk papillary thyroid microcarcinoma (PTMC) through immediate surgery (IOP) or delayed surgery after active surveillance (DOP). DOP was an alternative to immediate surgery. Among the 516 patients undergoing surgery, DOP patients had larger tumors, more lymphatic invasion, and multifocality. However, rates of complications didn’t significantly differ. Disease progression […]

This multicenter study investigated the use of autofluorescence, specifically the Fluobeam® LX device, in thyroid surgery. Researchers aimed to determine if it helps identify and protect parathyroid glands during total thyroidectomy, potentially reducing low parathyroid hormone (PTH) levels after surgery. Among 535 patients, autofluorescence didn’t significantly lower low PTH levels in the entire group, but […]

A study exploring healthcare cost-efficiency in thyroid surgeries found that high-volume endocrine surgeons, performing over 50 cases annually, managed thyroidectomies at significantly lower costs compared to their low-volume counterparts. The cost reduction was even more pronounced when cases were categorized by relative value units, demonstrating that experienced surgeons can deliver cost-effective care without compromising quality. […]